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Experimental priming of encephalitogenic
Th1/Th17 cells requires pertussis toxin-driven
IL-1b production by myeloid cells
Francesca Ronchi1,*,w, Camilla Basso1,*, Silvia Preite1, Andrea Reboldi1,w, Dirk Baumjohann1,w, Luana Perlini1,
Antonio Lanzavecchia1,2 & Federica Sallusto1
CD4þ Th17 are heterogeneous in terms of cytokine production and capacity to initiate
autoimmune diseases, such as experimental autoimmune encephalomyelitis (EAE). Here we
demonstrate that experimental priming of encephalitogenic Th cells expressing RORgt and
T-bet and producing IL-17A, IFN-g and GM-CSF but not IL-10 (Th1/Th17), is dependent on the
presence of pertussis toxin (PTX) at the time of immunization. PTX induces early production
of IL-1b by CD11bþCCR2þGr1þ myeloid cells, which are rapidly recruited to antigen-draining
lymph nodes. PTX-induced generation of Th1/Th17 cells is impaired in IL-1b- and
ASC-deﬁcient mice and in mice in which myeloid cells are depleted or fail to migrate to lymph
nodes and requires expression of IL-1R1 and MyD88 on both T cells and non-T cells.
Collectively, these data shed light on the enigmatic function of PTX in EAE induction and
suggest that inﬂammatory monocytes and microbial infection can inﬂuence differentiation of
pathogenic Th1/Th17 cells in autoimmune diseases through production of IL-1b.
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E
xperimental autoimmune encephalomyelitis (EAE) is a well-
established mouse model of multiple sclerosis (MS), a
debilitating inﬂammatory demyelinating disease of the
human central nervous system (CNS). Early studies established
that interleukin (IL)-17-producing CD4þ Th17 cells are required
to induce EAE, as mice lacking RORgt, the Th17-specifying
transcription factor, or IL-23, a Th17 growth and differentiation
factor, are resistant to EAE induction1–3. However, further studies
showed that not all Th17 are pathogenic. In particular, it has been
demonstrated that Th17 cells primed in vitro in the presence of
transforming growth factor (TGF)-b1 and IL-6 and producing
IL-17 and IL-10 are non-pathogenic when transferred in vivo in a
passive model of EAE4,5. In contrast, Th17 cells generated in vitro
in the presence of IL-6, IL-23 and IL-1b or TGF-b3 and IL-6 and
producing IL-17 together with interferon (IFN)-g are pathogenic
in vivo5,6. Furthermore, it has been shown that granulocyte–
macrophage colony-stimulating factor (GM-CSF) production by
Th17 cells, which is induced by IL-23 and RORgt, is required for
initiation of CNS inﬂammation7–9. A better deﬁnition of the
stimuli that induce the differentiation of IL-17þ /IFN-gþ /GM-
CSFþ T cells in vivo is essential to understand the initial events
that may lead to autoimmunity.
To trigger EAE in vivo, myelin oligodendrocyte glycoprotein
(MOG) or myelin proteolipid protein peptides are admixed with
complete Freund’s adjuvant (CFA) and injected subcutaneously
into mice or rats10. The addition at the time of immunization of
pertussis toxin (PTX)11, the major virulence factor of Bordetella
pertussis, was empirically found to greatly improve the efﬁciency
of EAE induction12,13 and to facilitate other murine autoimmune
disease models, such as experimental autoimmune myocarditis,
experimental autoimmune uveitis and glucose-6-phosphate
isomerase (GPI)-induced arthritis14–16. However, in spite of the
wide use, the mechanism by which PTX exerts its potent adjuvant
effect on the immune response has remained elusive. Early studies
indicated that PTX can increase permeability of blood vessels17,18,
while more recently it was found that PTX can promote TLR4-
dependent production of IL-1b and IL-6 by myeloid and stromal
cells and entry of leukocytes in the CNS in the effector phase
of EAE19.
In this study, we asked whether and how PTX can affect the
early events of T-cell differentiation. We report that PTX
promotes the priming of CD4þ T cells producing IL-17A,
IFN-g and GM-CSF, but not IL-10 (also deﬁned as Th1/Th17), by
inducing the rapid recruitment of neutrophils and inﬂammatory
monocytes in the antigen-draining lymph nodes and production
of IL-1b, which is required for the expansion and differentiation
of encephalitogenic Th1/Th17 cells in vivo.
Results
PTX promotes development of encephalitogenic Th1/Th17 cells.
To investigate the role of PTX in the early events of EAE
induction, we adoptively transferred CD90.1þ MOG-speciﬁc
naive 2D2 TCR-transgenic T cells into CD90.2þ C57BL/6 wild-
type (WT) mice and followed their fate upon subcutaneous (s.c.)
immunization with MOG peptide (MOG35–55) in CFA (MOG-
CFA). PTX (200 ng per mouse) or PBS was injected intravenously
(i.v.) on days 0 and 2. As shown in Fig. 1a, on day 5 after
immunization, the frequency and absolute numbers of 2D2 T
cells in the draining lymph nodes were signiﬁcantly higher in
PTX-treated mice as compared with PBS-treated control mice.
2D2 T cells were also found in higher numbers in the spleen and
the brain of PTX-treated mice, peaking on day 7 (Supplementary
Fig. 1a). 2D2 T cells from PTX-treated mice were larger and
enriched in lipid rafts and were able to proliferate in vitro at lower
concentrations of MOG as compared with 2D2 T cells from
lymph nodes of PBS-treated mice (Supplementary Fig. 1b,c).
Remarkably, although following restimulation in vitro with MOG,
2D2 T cells from PTX- and PBS-treated mice produced IL-17 at
comparable levels, only 2D2 T cells from PTX-treated mice
produced high levels of IFN-g and GM-CSF and only 2D2 T cells
from PBS-treated produced IL-10 (Fig. 1b). 2D2 T cells from
PTX-treated mice produced also IL-22 in signiﬁcantly higher
amounts compared with cells from PBS-treated mice. These data
were conﬁrmed by intracellular cytokine staining that showed
that a large proportion of 2D2 T cells from PTX-treated mice
produced simultaneously IL-17, IFN-g and GM-CSF (Fig. 1c).
Consistent with the cytokine proﬁle, T-bet and RORgt mRNAs
were more abundantly expressed by 2D2 T cells from
PTX-treated mice, whereas mRNAs for the arylhydrocarbon
receptor (AhR) and IL-23R were expressed at comparable levels
(Fig. 1d). Injection of PTX in MOG-CFA-immunized WT mice
(with no adoptive transfer of 2D2 T cells) resulted in a higher
proportion of endogenous CD4þ T cells expressing CD40L and
producing IL-17, IFN-g and GM-CSF upon restimulation in vitro
with MOG (Supplementary Fig. 2a,b), indicating that the effect of
PTX is not restricted to transgenic 2D2 T cells. As expected,
PTX-treated, but not PBS-treated, mice developed EAE following
immunization, with prominent inﬁltration of CD4þ T lympho-
cytes in the CNS (Supplementary Fig. 3a–c). Collectively, these
data indicate that PTX potently synergizes with CFA to promote
the early expansion and differentiation of highly responsive and
encephalitogenic T cells that produce IL-17A, IFN-g and
GM-CSF and no IL-10 (hereafter deﬁned as Th1/Th17).
The synergistic effect of PTX requires enzymatic activity. To
determine whether PTX could synergize with other adjuvants and
in different experimental settings, we adoptively transferred
CD4þ or CD8þ TCR transgenic T cells (2D2 T cells speciﬁc for
MOG, OT-II and OT-I cells speciﬁc for ovalbumin, TCR7 cells
speciﬁc for hen egg lysozyme) into congenic mice, which were
then immunized with the relevant antigen together with CFA,
LPS or bacterial extracts. In all cases, we observed that the
enzymatically active PTX dramatically increased the proportion
of T cells that produced three or more cytokines (IL-17A, IFN-g,
IL-22 and/or GM-CSF), also deﬁned as multifunctional T cells
(Supplementary Fig. 4a–c). In contrast, a non-toxic PTX mutant
devoid of ADP-ribosylating activity20 failed to synergized with
CFA (Supplementary Fig. 4d,e). We concluded that the
synergistic effect of PTX in the induction of multifunctional T
cells can be observed with different antigens and adjuvants and is
dependent from the PTX enzymatic activity.
PTX-induction of Th1/Th17 cells requires IL-1b but not IL-23.
To investigate the mechanisms that lead to the induction of Th1/
Th17 cells, we ﬁrst analysed the cytokines induced in the draining
lymph nodes at different time points after immunization with
MOG-CFA and injection of PBS or PTX on day 0 and day 2. PBS
injection did not induce upregulation of any of the cytokines analysed
(Fig. 2a). In contrast, each PTX injection was followed by a rapid
increase, up to 100-fold, of pro-IL-1b mRNA (Fig. 2a), whereas
mRNAs for other cytokine genes, such as IL-1a, IL-6, pro-IL-18 and
IL-23, were not signiﬁcantly affected. Second, we transferred naı¨ve
CD90.1þ 2D2 T cells into CD90.2þ C57BL/6 mice lacking IL-1b,
IL-12 or IL-23. Mice were immunized and T cells in the draining
lymph nodes were analysed at day 5. When transferred into Il1b–/– or
Asc–/– mice (both lacking mature IL-1b), 2D2 T cells expanded
poorly and, although they acquired the capacity to produce IL-17, did
not acquire the capacity to produce IFN-g and GM-CSF and
produced high amounts of IL-10 (Fig. 2b–d). As expected, when
analysed at late time points, Il1b–/– and Asc–/– mice did not develop
or developed a signiﬁcantly milder disease compared with WT
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11541
2 NATURE COMMUNICATIONS | 7:11541 | DOI: 10.1038/ncomms11541 | www.nature.com/naturecommunications
cb
IL
-1
7A
IL-22
IL
-1
7A
GM-CSF
IL
-1
7A
NSNS
NS
NS
NS
*
*
a
0
20
40
60
80
100
2D
2 
ce
lls
 in
 D
LN
 (×
10
–
3 )
0
1
2
3
4
5
***
NS
43.3
25.9
8.6
9.4
1.7
38.9
44.0
22.0
7.9
0 102 103 104 105
0
102
103
104
105 38.8
9.0
9.6 9.5
7.5
38.9
37.8
25.5
14.1
2D
2 
ce
lls
 in
 D
LN
 (%
)
0
2,000
4,000
6,000
8,000
T-bet
0
5,000
10,000
15,000
 
m
R
N
A 
(A
U)
 
0
2,000
4,000
6,000
8,000
10,000
0
2,000
4,000
6,000
RORγt AhR IL-23R
MOG-CFA
 + 2xPBS
MOG-CFA
+ 2xPTX 
IFN-γ
**
d
Day 5
IFN-γ
****
0.0
0.5
1.0
1.5
2.0
2.5
n
g 
m
l–1
NS
0.0
0.2
0.4
0.6
0.8
IL-17
1.0
0.0
0.2
0.4
0.6
0.8
IL-22
** ***
0.0
0.5
1.0
1.5
2.0
GM-CSF
2.5
MOG-CFA + 2xPBS
MOG-CFA + 2xPTX
Naive
MOG-CFA + 2xPBS
MOG-CFA + 2xPTX
***
0.0
0.3
0.6
0.9
1.2
IL-10
MOG-CFA + 2xPBS
MOG-CFA + 2xPTX
0 102 103 104 105
0
102
103
104
105
0 102 103 104 105
0
102
103
104
105
0 102 103 104 105
0
102
103
104
105
0 102 103 104 105
0
102
103
104
105
0 102 103 104 105
0
102
103
104
105
Figure 1 | PTX induces encephalitogenic Th1/17 cells. (a) Mean percentage and absolute number of CD90.1þ CD4þ 2D2 TCR-transgenic T cells
measured by ﬂow cytometry in the draining lymph nodes (DLN) of CD90.2þ C57BL/6 mice on day 5 after immunization with MOG-CFA and injection of
PBS or PTX on day 0 and day 2. Each symbol represents an individual mouse (n¼ 5). Data are representative of more than ﬁve independent experiments,
with at least 3 mice per group. (b) IL-17A, IL-22, IFN-g, GM-CSF and IL-10 protein abundance in culture supernatants of ﬂow cytometry-sorted CD90.1þ
CD4þ 2D2 T cells isolated from DLN of immunized mice and restimulated in vitro with bone marrow-derived LPS-matured DCs pulsed with 20mgml 1
MOG35–55. Cytokines were assessed by ELISA after 72 h of culture. Data are meanþ s.e.m. (n¼ 3) and are representative of two independent experiments
with 3–4 mice per group. (c) Representative ﬂow cytometry analysis of cytokine staining of CD90.1þ CD4þ 2D2 Tcells isolated from DLN of mice on day
5 after immunization and restimulated in vitro for 5 h with phorbol 12-myristate 13-acetate (PMA) and ionomycin in the presence of brefeldin A (BFA) for
the last 3 h. Data are representative of more than ﬁve independent experiments with at least 3 mice per group. (d) T-bet, RORgt, AhR and IL-23R mRNA
abundance in 2D2 Tcells. CD90.1þ CD4þ 2D2 Tcells were isolated from DLN of mice on day 5 after immunization and analysed by reverse transcription–
PCR. Naı¨ve CD4þ T cells were included as control. AU, arbitrary units. Data are meanþ s.e.m. (n¼ 3) and are representative of two independent
experiments with 3–4 mice per group. *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001, as determined by nonparametric unpaired Mann–Whitney test.
NS, not signiﬁcant.
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control mice (Supplementary Fig. 5a). In contrast, when transferred
into Il12p35 / mice (that lack IL-12 and IL-35) or Il12p40–/– mice
(that lack IL-12 and IL-23), 2D2 T cells expanded and differentiated
to Th1/Th17 cells as in WT mice (Fig. 2e,f). Differentiation of Th1/
Th17 cells was also observed in IL-23R-deﬁcient OT-II T cells
transferred in WT mice immunized with OVA-CFAþ PTX
(Supplementary Fig. 5b). However, mice lacking IL-23 (Il12p40–/–
and Il23p19–/–) did not develop EAE (Supplementary Fig. 5c), con-
sistent with previous results21,22 and supporting the notion that IL-23
is required for ampliﬁcation and stabilization of the Th1/Th17
phenotype23.
Collectively, these observations imply that the key factor for the
initial priming of encephalitogenic Th1/Th17 cells is IL-1b, which
is acutely induced by PTX in the draining lymph nodes.
PTX induces recruitment of IL-1b-producing myeloid cells. To
further investigate the mechanisms that lead to PTX-dependent
IL-1b production, we analysed the cellular composition of the
draining lymph nodes of mice immunized with MOG-CFA and
injected with PTX or PBS on day 0 and day 2. On day 5 after
immunization, the absolute numbers of CD11bþ Gr1hi Ly6Cint
Ly6Gþ neutrophils and CD11bþ Gr1int Ly6Chi Ly6G– inﬂam-
matory monocytes in the draining lymph nodes dramatically
increased in PTX-treated mice as compared with PBS-treated
control mice (Fig. 3a). Several inﬂammatory chemokines,
including CXCL2, CCL2 and CXCL10, were detected at high
levels in the draining lymph nodes of immunized mice injected
with PTX, but not with PBS (Supplementary Fig. 6a,b), providing
a plausible mechanism for the recruitment of neutrophils and
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Figure 2 | IL-1b is required for priming of Th1/17 cells. (a) Cytokine mRNA abundance measured by quantitative PCR in DLN at different time points after
immunization with MOG-CFA and injection of PBS or PTX on day 0 and day 2 (arrows). Data are meanþ s.e.m. (n¼4) and are representative of two
independent experiments with 3–4 mice per group. AU, arbitrary units. (b) Absolute number of CD90.1þ CD4þ 2D2 Tcells measured by ﬂow cytometry
in DLN from WT, Asc / and Il1b / mice on day 5 after immunization. Each symbol represents an individual mouse. Data are meanþ s.e.m. (n¼4–6)
and are representative of more than three independent experiments with at least 3 mice per group. (c,d) Percentage of IL-17þ and IFN-gþ/GM-CSFþ 2D2
Tcells measured by intracellular cytokine staining (c) and concentration of IL-10 in culture supernatants measured by ELISA (d) of 2D2 Tcells from DLN of
WTor Il1b / mice on day 5 after immunization. CD90.1þ CD4þ 2D2 Tcells were sorted and stimulated in vitro for 5 h with PMA and ionomycin in the
presence of BFA for the last 3 h (c) or for 72 h with LPS-matured MOG35–55-pulsed DCs (d). Data are meanþ s.e.m. (n¼ 3) and are representative of
two independent experiments with at least 3 mice per group. (e) Absolute number of 2D2 T cells (CD90.1þ CD4þ ) in DLN of WT, Il12p35 / and
Il12p40 / mice measured by ﬂow cytometry on day 5 after immunization with MOG-CFA and injection of PBS or PTX on day 0 and day 2. Each symbol
represents an individual mouse. Data are meanþ s.e.m. (n¼ 3–4) and are representative of two independent experiments with at least 3 mice per group.
(f) Percentage of IL-17þ and IFN-gþ/GM-CSFþ 2D2 Tcells measured by intracellular cytokine staining in DLN of WT, Il12p35 / or Il12p40 / mice on
day 5 after immunization. Data are meanþ s.e.m. (n¼ 3–5) and are representative of three independent experiments with at least 3 mice per group.
*Po0.05; **Po0.01, ***Po0.001, ****Po0.0001, as determined by nonparametric unpaired Mann–Whitney test. NS, not signiﬁcant.
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monocytes that express the cognate receptors CXCR1, CXCR2
and CCR2. Importantly, PTX injection in Asc–/– and Il1b–/– mice
did not induce recruitment of myeloid cells in the draining lymph
node and did not trigger chemokine production (Fig. 3b and
Supplementary Fig. 6c). Interestingly, in WT mice, injection of
PTX alone on day 0 and day 2 induced neutrophil and monocyte
recruitment in lymph nodes (Fig. 3c). In particular, although the
ﬁrst injection of PTX led to a transient increase in the number of
neutrophils and monocytes, the second injection resulted in a
sustained increase that lasted for several days. Injection of PTX
alone induced also recruitment of neutrophils and monocytes in
the spleen and the brain (Supplementary Fig. 7a,b).
To identify which cells in the draining lymph node of
immunized mice were responsible for IL-1b production in
response to PTX, we used two different approaches. First, we
isolated from immunized mice treated with PBS or PTX different
cell types and measured their spontaneous production of IL-1b.
As shown in Fig. 4a, CD11cþ dendritic cells (DCs), CD11bþ
Gr1int Ly6Chi Ly6G– inﬂammatory monocytes and F4/80þ
macrophages isolated from PTX-treated mice, spontaneously
released mature IL-1b when cultured in the absence of additional
stimuli. Furthermore, both CD11cþ and CD11bþ cells produced
mature IL-1b when exposed to PTX in vitro (Supplementary
Fig. 8). Second, we depleted different cell populations in vivo and
monitored expression of pro-IL-1b in the draining lymph nodes
of immunized mice treated with PBS or PTX. A dramatic
decrease in pro-IL-1bmRNA expression in draining lymph nodes
was observed in mice treated with an anti-Gr1 antibody (RB6-
8C5, depleting neutrophils and monocytes) and in Ccr2–/– mice,
in which recruitment of inﬂammatory myeloid cells is impaired,
but not in mice treated with an anti-Ly6G antibody (1A8,
depleting neutrophils; Fig. 4b). In contrast, depletion of F4/80þ
macrophages (by clodronate liposome treatment, Supplementary
Fig. 9) or CD11cþ cells (in bone marrow CD11c-DTR chimeric
mice, Supplementary Fig. 10) did not result in signiﬁcant changes
in pro-IL-1b mRNA in immunized mice.
To address the potential role of Gr1þ cells, and in particular of
CCR2þ monocytes, in the induction of Th1/Th17 cells, we
analysed the phenotype of 2D2 T cells primed in mice that were
depleted of these cells. In mice treated with the Gr1-depleting
antibody and in Ccr2–/– mice, but not in mice treated with the
Ly6G-depleting antibody or depleted of F4/80þ or CD11cþ cells,
2D2 T cells did not expand in response to PTX and did not
acquire the Th1/Th17 phenotype (Fig. 4c–e and Supplementary
Figs 9 and 10). However, transfer of WT CCR2þ monocytes into
Ccr2–/– mice was sufﬁcient to reconstitute the PTX-dependent
differentiation of Th1/Th17 cells (Fig. 4f).
Collectively, these results indicate that PTX induces recruit-
ment of IL-1b-producing CCR2þ myeloid cells required for
priming of Th1/Th17 cells producing IL-17A, IFN-g and
GM-CSF.
IL-1R1-signalling is required on T cells and non-T cells. Having
found a role for IL-1b in the recruitment of myeloid cells and in
the differentiation of Th1/Th17 cells, we were interested to
establish in which compartment IL-1b signalling was required. To
this end, we crossed 2D2 transgenic mice with Il1r1–/– mice and
transferred Il1r1–/– 2D2 T cells into WT hosts. We also trans-
ferred wt 2D2 T cells into Il1r1–/– hosts. Mice were immunized
with MOG-CFA and injected on days 0 and 2 with PBS or PTX.
In WT recipient immunized with MOG-CFA alone, the expan-
sion of WT and Il1r1–/– 2D2 T cells was comparable (Fig. 5a),
indicating that, in a CFA-driven response, IL-1b signalling is
dispensable in T cells. In contrast, in WT recipient immunized
with MOG-CFA and receiving PTX, expansion of Il1r1–/– 2D2 T
cells was signiﬁcantly reduced (Fig. 5a). Although there was no
signiﬁcant reduction in the percentage of IL-17þ or IFN-gþ /
GM-CSFþ cells, the absolute number of Il1r1–/– 2D2 T cells that
acquired the IFN-gþ /GM-CSFþ phenotype was signiﬁcantly
reduced (Fig. 5b). In these mice, recruitment of neutrophils and
monocytes in the draining lymph node was also signiﬁcantly
impaired (Fig. 5c), suggesting a positive feedback mechanism
induced by GM-CSF produced by Th1/Th17 cells in the
recruitment or activation of myeloid cells in the draining lymph
node24. In Il1r1–/– hosts, PTX failed to induce expansion of
adoptively transferred wt 2D2 T cells (Fig. 5a). In these mice,
frequency and absolute number of WT 2D2 T cells that acquired
the IFN-gþ /GM-CSFþ phenotype were signiﬁcantly reduced
(Fig. 5b). In addition, the PTX-induced recruitment of
neutrophils and monocytes in the draining lymph nodes was
abolished (Fig. 5c).
Finally, we analysed the response of WT 2D2 T cells
transferred into mice deﬁcient for MyD88, an adaptor molecule
that is known to be required for IL-1R1 and Toll-like receptor
(TLR) signalling25, and into Tlr4–/–, Tlr2–/– or Tlr9–/– mice.
There was a marked reduction of 2D2 T-cell expansion and
differentiation to Th1/Th17 cells and of recruitment of
neutrophils and monocytes in immunized Myd88–/– mice
treated with PTX (Supplementary Fig. 11a–c). In contrast,
although there was a slight reduction in the number of 2D2 T
cells detected on day 5 in the draining lymph nodes, the
differentiation to Th1/Th17 cells and the recruitment of
neutrophils and monocytes were not affected in immunized
Tlr–/– mice (Supplementary Fig. 11d–f).
Collectively, these ﬁndings indicate that IL-1b can act directly
on activated T cells to promote the expansion and differentiation
of T cells producing IL-17, IFN-g and GM-CSF. They also
indicate that the IL-1R1-MyD88 signalling on host cells, most
likely in the draining lymph nodes, is required for the recruitment
of inﬂammatory myeloid cells and for the generation of
encephalitogenic Th1/Th17 cells.
Discussion
In this study, we deﬁne in vivo conditions that promote the rapid
generation of Th1/Th17 cells producing IL-17, IFN-g and GM-
CSF, but not IL-10, and expressing RORgt and T-bet. The
cytokine primarily involved in the differentiation of these highly
inﬂammatory multifunctional T cells is IL-1b produced by
CCR2þ myeloid cells that are recruited at early time points in the
draining lymph nodes in a PTX-dependent manner. These
ﬁndings reveal an in vivo mechanism for the generation of Th1/
Th17 cells through microbial induction of IL-1b and provide an
explanation for the enigmatic role of PTX in the enhancement of
EAE.
PTX is used in most EAE models and in other models of
autoimmune diseases, such as autoimmune myocarditis, auto-
immune uveitis or GPI-induced arthritis14–16. In the EAE model,
it has been shown that PTX facilitates leukocyte recruitment in
the CNS by increasing permeability across the blood–brain
barrier, an effect that is at least partly dependent on TLR4 (refs
19,26). PTX injection was also shown to reduce frequency and
suppressive activity of splenic Treg cells, whereas in vitro PTX-
treated splenic cells, which produced IL-6 and other
proinﬂammatory cytokines, overcame the inhibition of
proliferation in co-cultures of Treg and CD4þCD25– T effector
cells27–29. In vitro, PTX induced generation of IL-17-producing T
cells, an effect that was markedly inhibited by anti-TGF-b
antibodies29. Our results show that in vivo PTX can act at early
time points to promote the differentiation in draining lymph
nodes of highly inﬂammatory T cells, producing IL-17, IFN-g and
GM-CSF, a ﬁnding that may explain its capacity to promote a
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broad variety of inﬂammatory diseases in different tissues. EAE
may be dependent on the combined effects of cytokines produced
by these multifunctional Th1/Th17 cells that can enhance
recruitment and function of innate and adaptive immune cells
in the brain and also activate microglia and impair the barrier
function of brain endothelial cells8,30–34.
PTX is composed of ﬁve subunits (S1 to S5); the S1 subunit has
the enzymatic activity that catalyses ADP-ribosylation of the a
subunit of trimeric G proteins, leading to a variety of biological
activities, whereas the S2–S5 subunits, which together form the B
oligomer, are responsible for binding of the toxin to target cell
receptors and internalization via receptor-mediated endocyto-
sis35. Although it was shown that the oligomer B is sufﬁcient to
stimulate T-cell proliferation in the presence of APCs or
ﬁbroblasts36, our data demonstrate that the ADP-ribosyl
transferase activity is required to induce myeloid cell
recruitment and generation of Th1/Th17 cells. These data are
consistent with those reported by Dumas et al., showing that the
ability of PTX to induce IL-1b transcription in peritoneal
leukocytes and secretion of IL-1b and IL-6 in the peritoneal
ﬂuid depends on the integrity of its ADP-ribosyltransferase
activity19.
It has been clearly established that Th17 cells come in different
ﬂavours and that not all Th17 cells are pathogenic37. The Th1/
Th17 cells that are induced in vivo in the presence of PTX resemble
the pathogenic Th17 cells induced by in vitro priming of naı¨ve T
cells in the presence of IL-23, IL-6 and IL-1b or TGF-b3 and IL-6
(refs 5,6). In both cases, the cells express RORgt and T-bet and
produce IL-17A and IFN-g, but not IL-10. In addition, we have
shown that the PTX-induced Th1/Th17 cells produce high
amounts of GM-CSF, an essential cytokine to initiate
neuroinﬂammation7–9. We have also found that while IL-1b was
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essential to induce Th1/Th17 in the antigen-draining lymph nodes,
IL-23 or IL-12 were not required at this early time point, but IL-23
was required to trigger EAE. These data support the notion that
different cytokines are involved in the early and late phases of EAE
to generate and maintain encephalitogenic T cells38.
Previous studies have described a role of inﬂammatory
monocytes in the effector phase of EAE. Mice that lack CCR2,
a chemokine receptor that binds to monocyte chemoattractant
protein 1 (MCP-1/CCL2) that is highly expressed in the inﬂamed
CNS, have reduced number of inﬂammatory monocytes in the
CNS, fail to develop EAE after active immunization and are
resistant to induction of EAE by adoptive transfer of encepha-
litogenic T cells39,40. Moreover, studies in MCP-1-deﬁcient mice
have indicated an important role for the CCR2-MCP-1 axis in
recruitment into the CNS of circulating monocytes and
macrophage precursors, which are required for primed T cells
to execute their effector functions in the tissue41. In this study, we
have shown for the ﬁrst time that the adjuvant effect of PTX is
mediated through the CCR2-dependent early recruitment in
lymph nodes of Gr1þ CCR2þ myeloid cells that produce high
levels of IL-1b. It is possible that blocking monocyte extravasation
in lymph nodes as well as in the CNS may result in a synergistic
effect by limiting both generation and effector function of
encephalitogenic T cells.
The important role of IL-1b in the induction of a subset of
inﬂammatory Th1/Th17 cells and its involvement in autoimmune
diseases such as MS was previously shown by several groups,
including ours42–46. By linking PTX to IL-b production and
induction of Th1/Th17 cells, our study provides a plausible
explanation for the disease-inducing effect of PTX, in addition to
the recently reported effects of PTX-induced IL-b in the
upregulation of adhesion molecules on blood–brain capillaries
that enhances the recruitment of inﬂammatory leukocyes into the
brain19. The identiﬁcation of endogenous or environmental
factors that can affect human Th17 function in a way similar to
those induced by PTX and described in this study may provide
new insights into the pathogenic mechanisms of MS and other
Th17-mediated autoimmune diseases.
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Methods
Mice. C57BL/6J mice were obtained from Harlan (Italy). Il1b / C57BL/6 mice47
were provided by Y. Iwakura and M. Bachmann. Asc / C57BL/6 mice48 were
provided by V. Dixit and J. Tschopp. Il12p35 / , Il23p19 / and Il12p40 /
C57BL/6 mice49 were provided by B. Becher. Myd88 / , Tlr4 / , Tlr9 / and
Tlr2 / C57BL/6 mice50–53 were provided by S. Akira and M. Manz. Il1r1 /
mice54 were provided by M. Kopf and backcrossed on C57BL/6 background for at
least ten generation before use. Ccr2 / C57BL/6 mice55 were from Jackson
Laboratory (004999). TCR7 TCR transgenic C57BL/6 mice56 were provided by A.
O’Garra. OT-II and OT-I TCR-transgenic C57BL/6 mice57,58 were purchased from
Jackson laboratory (004194 and 003831, respectively) and bred in our facility. 2D2
TCR-transgenic C57BL/6 mice59 (006912, Jackson Laboratory) were bred onto
backgrounds of various CD90 alleles and crossed with Il1r1 / and
Myd88 /mice. Mice were maintained under speciﬁc pathogen-free conditions at
the Institute for Research in Biomedicine Animal Facility. Mice were treated in
accordance with guidelines of the Swiss Federal Veterinary Ofﬁce and experiments
were approved by the Dipartimento della Sanita` e Socialita`. Female mice were used
between 5 and 10 weeks of age.
EAE model and in vivo experiments. Mice were immunized s.c. on day 0 with
150mg of MOG35–55 peptide (MEVVGWYRSPFSRVVHLYRNGK; Servei de
Proteo`mica, Pompeu Fabra University, Barcelona, Spain) emulsiﬁed in CFA
(incomplete Freund’s adjuvant plus 4mgml 1 of Mycobacterium tuberculosis
H37RA, Difco). PTX (Sigma) was injected at 200 ng per injection per mouse in
200ml saline i.v. on day 0 and day 2. Control mice received 200 ml of PBS only. In
some experiments, MOG-CFA immunized mice were injected on day 0 and day 2
with a 9K/129G PTX mutant20 (provided by R. Rappuoli). Disease severity was
assigned as described previouly10. For adoptive transfer, naı¨ve CD90.1þ 2D2 T
cells (0.3–1 105 per mouse) were injected i.v. 16 h before immunization. In some
adoptive transfer experiments, naive CD8þ OT-I cells, naive CD4þ TCR7 or
naı¨ve OT-II T cells (0.3–1 105 per mouse) were injected i.v. 16 h before
immunization. Then mice were immunized s.c. with the relevant antigen emulsiﬁed
in CFA. MHC class I-binding peptide SIINFEKL (OVA amino acids 257–264,
15mg per mouse) and OVA323–339 peptide (SQAVHAAHAEINEAGR 30 mg per
mouse) were obtained from Servei de Proteo`mica, Pompeu Fabra University,
Barcelona, Spain. Hen egg lysozyme peptide (HEL46–61, 50mg per mouse) was
purchased from Anaspec. In other experiments, mice were immunized s.c. with
antigen in combination with 15 mg per mouse of LPS (ultrapure Escherichia coli
O111-BA LPS, Invivogen), 0.8mg per mouse of M. tuberculosis (H37RA, Difco) or
with E. coli or Streptococcus pyogenes (heat inactivated, pathogen extracts), as
adjuvants. To deplete Gr1þ cells, a-Gr1 antibody (clone RB6-8C5 from BioXCell)
or rat IgG2b isotype control antibody (clone LTF2 from BioXCell) was injected
daily intraperitonally (i.p.) at a dose of 400 mg per mouse. To deplete Ly6Gþ cells,
a-Ly6G antibody (clone 1A8 from BioXCell) or rat IgG2a isotype control antibody
(clone 2A3 from BioXCell) was injected daily i.p. at a dose of 400mg per mouse.
Frequency of neutrophils in lymph node was drastically reduced in RB6-8C5-
treated mice compared with LTF2-treated mice (mean±s.e.m. (n¼ 4): 12.1±3.9%
versus 26.5±4.2% PBS, 16.7±4.0% versus 59.2±6.2% PTX) and in 1A8-treated
mice compared with 2A3-treated mice (mean±s.e.m. (n¼ 3): 1±0.6% versus
12.9±3.7% PBS, 4.5±2.6% versus 44.5±7.2% PTX). To deplete macrophages,
clodronate-liposomes or control liposomes (1mg per 200 ml) were administered i.p.
daily, starting on day –2 before immunization60. CD11c-DTR bone marrow
chimeras were generated through reconstitution of sublethally irradiated
RAG1 / female mice with 2 106 bone marrow cells from CD11c-GFP-DTR
C57BL/6 donor female mice. Chimeras were used 2 months after successful
reconstitution. Diphtheria toxin was administered daily i.p. for 5 days at a dose of
4 ng per g of body weight.
Cell preparation and isolation from tissues. To isolate naı¨ve T cells from the
different mouse strains, cells from the spleen and lymph nodes were ﬁrst enriched
with anti-CD4 magnetic beads (L3T4, Miltenyi Biotec) and then sorted on a
FACSAria Cell Sorter (BD Biosciences) to obtain cells with a CD4þCD8
CD25CD44lowCD62Lhigh phenotype. To study T cells primed in vivo, mice were
killed on day 5, or as indicated, and CD90.1þ 2D2 T cells or endogenous
CD90.1CD90.2þ CD4þ T cells from lymphoid organs and the brain were ﬁrst
enriched with anti-CD90.1 or anti-CD4 beads (Miltenyi Biotech) and then further
puriﬁed by FACS sorting. Dead cells were always excluded by staining with
7-aminoactinomycin D (7-AAD) (BioLegend). In preliminary experiments, day 5
was chosen as optimal time point for the analysis of T cells from draining lymph
node (Supplementary Fig. 12). Myeloid cells from draining lymph nodes and
lymphocytes from CNS were isolated after dissecting the organ and incubation of
45min at 37 C in a solution with 1mgml 1 of Collagenase D and 40 mgml 1 of
DNase I (Roche). Cells were then passed through a Nylon ﬁlter 40 mm and residues
were smashed. After washing, cells from the CNS were separated on Percoll (GE
Healthcare) gradient (70:37%) to obtain mononuclear cells. Bone marrow-derived
DCs were generated according to a standard protocol61 using the supernatant of a
GM-CSF-producing cell line62,63. Il23r–/– splenocytes were provided by F. Powrie,
and CD4þ naı¨ve T cells were isolated as described above for adoptive transfer
experiments. Inﬂammatory monocytes were isolated from bone marrow of WT
animals by depletion of magnetically labelled T cells, B cells, NK cells, DCs,
erythroid cells and granulocytes using the monocyte isolation kit (Miltenyi
Biotech), as previously described64. In all preparations, Ly6Ghi neutrophils were
less than 5% of CD11bþ isolated cells.
Flow cytometry. For analysis of mouse cell phenotypes, the following monoclonal
antibodies were used: a-CD3 (clone: 145-2C11), a-CD4 (RM4-5), a-CD8a
(53–6.7), a-CD25 (PC61), a-CD44 (IM7), a-CD62L (MEL14), a-CD90.1 (OX-7),
a-CD40L (MR-1), a-CD11c (HL3), a-CD11b (M1/70), a-Gr1 (RB6-8C5), a-Ly6C
(HK1.4), a-Ly6G (1A8), a-F4/80 (BM8), a-IFN-g (XMG1.2), a-IL-17A (TC11-
18H10), a-GM-CSF (MP1-22E9; all from BioLegend) and a-IL-22 (AM22-3;
provided by J.C. Renauld). For staining of lipid rafts, biotin-conjugated cholera
toxin subunit B (Molecular Probes) was used together with ﬂuorochrome-con-
jugated streptavidin (BioLegend). Dead cells were always excluded by staining with
7-AAD (BioLegend) or 4,6-diamidino-2-phenylindole (Sigma). All antibodies were
used at 1 mg per 106 cells. For intracellular cytokine staining, cells were stimulated
for 5 h with phorbol 12-myristate 13-acetate (10 7M; Sigma) and ionomycin
(1 mgml 1; Sigma), in the presence of brefeldin A (10 mgml 1; Sigma) for the last
3 h of culture. Cells were ﬁxed with 4% (wt/vol) paraformaldehyde and permea-
bilized with 0.5% (wt/vol) saponin (Sigma). Eight-colour staining was performed
with the appropriate combinations of antibodies conjugated to ﬂuorochromes.
Samples were acquired on a FACSCanto II (BD Biosciences) and analysed with
FlowJo software (TreeStar) and when necessary using the Boolean gating strategy65.
In vitro experiments. 7-AAD– CD4þ CD90.1þ 2D2 T cells were sorted from
draining lymph nodes on day 5 after immunization, labelled with carboxy-
ﬂuorescein succinimidyl ester (CFSE) and cultured (2 104 cells per well) in
round-bottom 96-well plates with glutaraldehyde-ﬁxed MOG35–55-pulsed, LPS-
matured, DCs (1 104 cells per well), as described previously63. In other
experiments, 7-AAD– CD4þ CD44þ T cells were sorted from draining lymph
nodes on day 5 after immunization, labelled with CFSE and cultured (3 104 cells
per well) in round-bottom 96-well plates with irradiated MOG35–55-pulsed
splenocytes from Rag1–/– mice (5 104 cells per well). T-cell proliferation was
assessed by ﬂow cytometry on the basis of CFSE dilution after 72 h of culture.
Supernatants of the T-cell cultures were harvested and analysed by ELISA. DC
stimulation was induced by overnight incubation with 0.5 mgml 1 LPS (ultrapure
E. coli O111-BA LPS, Invivogen). To induce IL-1b secretion, 0.1mgml 1 ATP-g-S
(Sigma) was added in the cell culture medium for the last 30–45min of incubation.
Supernatants of the culture was then harvested and analysed by ELISA.
Quantitative real-time PCR. RNA was prepared from transferred 2D2 T cells
or from total draining lymph node cells using TRIzol LS reagent (Invitrogen)
according to the manufacturer’s instructions. Draining lymph nodes were
dissected, cut into pieces and incubated for 45min at 37 C with 1mg/ml of
Collagenase D and 40 mg/ml of DNase I (both from Roche). The cell suspension
was passed through nylon ﬁlter (40 mm) and then processed for cell sorting and
RNA extraction or directly for RNA extraction or protein analysis. RNA was
transcribed into cDNA, and analysed as described before66. Brieﬂy, random
primers and MMLV Reverse Transcriptase (Invitrogen) were used for cDNA
synthesis. Transcripts were quantiﬁed by real-time quantitative PCR on an ABI
PRISM 7,700 Sequence Detector (Perkin-Elmer Applied Biosystems) with Applied
Biosystems predesigned TaqMan Gene Expression Assays and reagents according
to the manufacturer’s instructions. The following probes were used (identiﬁed by
Applied Biosystems assay identiﬁcation number): Tbx21 (Mm00450960_m1), Rorc
(Mm01261019_m1), Ahr (Mm00478932_m1), Il23r (Mm00519943_m1), Il1b
(Mm01336189_m1), Il-18 (Mm00434226_m1), Il23 (Mm00518984_m1), Il1a
(Mm00439620_m1), Il6 (Mm00446190_m1). For each sample, mRNA abundance
was normalized to the amount of 18S rRNA and expressed as arbitrary units.
Proteome proﬁler. Lymph node cells were lysed using RIPA lysis buffer and
proteinase inhibitors (Roche) to extract proteins. Protein concentration in the
tissue lysates was determined by bicinchoninic acid Protein Assay Reagent (Pierce).
Proteins from tissue lysates (70 mg) were analysed using a commercial kit (Mouse
cytokine array panel A Array kit, R&D Systems) containing nitrocellulose mem-
branes coated with 40 different anti-cytokine or anti-chemokine antibodies printed
in duplicate, following the manufacturer’s instructions. Chemiluminescenc was
measured by ImageQuantum LAS4000 (GE Healthcare Life Science) and signals
quantiﬁed using AIDA Evaluation Software (BioImaging).
ELISA. To measure cytokine concentration in cell culture supernatants, the
following ELISA kits were used: IL-1b (R&D Systems), IFN-g (BD Biosciences),
IL-17A (BD Biosciences), IL-22 (Antigenix America), GM-CSF (eBioscience), IL-
10 (eBioscience), IL-6 (R&D System). ELISA assays were performed according to
the manufacturer’s instructions.
Statistics. Data were analysed with Prism 5 (GraphPad Software) using the
nonparametric unpaired Mann–Whitney U-test. Graphs show the meanþ
standard error of the mean (s.e.m.). *Po0.05, **Po0.01, ***Po0.001,
****Po0.0001.
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